Omada Health, Inc. (OMDA) Tops Q1 EPS by 3c, provides guidance

Omada Health, Inc. (NASDAQ: OMDA) reported Q1 EPS of ($0.05), $0.03 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $78 million, versus $0 reported last year.

GUIDANCE:

Omada Health, Inc. sees FY2026 revenue of $322-330 million, versus the consensus of $318.9 million.

For earnings history and earnings-related data on Omada Health, Inc. (OMDA) click here.

You May Also Be Interested In

• Silver Lake In Talks To Buy Workday, Sources Say - Reuters
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'